Translational cancer research is dependent on extraction of human tissues. Much work has gone into optimizing extraction methods for ex vivo analysis. Here, we describe tissue processing methods allowing for maximal data output from limited samples.
A subscription to JoVE is required to view this content. Sign in or start your free trial.
Method Article
* These authors contributed equally
Translational cancer research is dependent on extraction of human tissues. Much work has gone into optimizing extraction methods for ex vivo analysis. Here, we describe tissue processing methods allowing for maximal data output from limited samples.
Medical research for human benefit is greatly impeded by the necessity for human tissues and subjects. However, upon obtaining consent for human specimens, precious samples must be handled with the greatest care in order to ensure integrity of organs, tissues, and cells to the highest degree. Unfortunately, tissue processing by definition requires extraction of tissues from the host, a change which can cause great cellular stress and have major repercussions on subsequent analyses. These stresses could result in the specimen being no longer representative of the site from which it was retrieved. Therefore, a strict protocol must be adhered to while processing these specimens to ensure representativeness. The desired assay(s) must also be taken into consideration in order to ensure that an optimal technique is used for sample processing. Outlined here is a protocol for tissue retrieval, processing and various analyses which may be performed on processed tissue in order to maximize downstream production from limited tissue samples.
Medical research has benefited immensely from the study of both human cell lines and animal models. Cell lines allow for better control of components in a system, as well as use of cells from the proper organism. Working with human cells, while more representative, presents a drastically simplified snapshot of mechanisms which may be responsible for health and disease, because cell lines may not recapitulate the impact of other cells, stromal components, and organs which may affect responses1. On the other hand, animal models, although not entirely accurate in reproducing human disease and genetic heterogeneity, offer further insight by allowing for input o....
Access restricted. Please log in or start a trial to view this content.
Ethics statement: This protocol is approved by the University of Texas MD Anderson Cancer Center.
1. Specimen Procurement
Access restricted. Please log in or start a trial to view this content.
The results displayed below depict flow cytometry gating strategy for broad immune phenotyping on a processed melanoma tumor. The day of staining, tissue sample was digested and homogenized with collagenase I and DNase I incubation for 60 min, at 37 °C under 225 RPM rotation. Following digestion, cell suspension was filtered through a 70 µm cell strainer to eliminate debris and cells were stained with fluorescence-labeled flow cytometry antibodies for immune cell phenotyping. Shown below (Figure 3) is th.......
Access restricted. Please log in or start a trial to view this content.
Ultimately, the methods of processing must be dictated by the desired hypothesis and anticipated technical assays to be performed (Figure 1). The following section serves as an overview to describe potential assays that may be performed on such tissue sections. It is by no means an exhaustive overview, but is intended to help guide sample processing methods and choice of downstream assays by describing techniques and listing their strengths and weaknesses.
Flow cytometry stain.......
Access restricted. Please log in or start a trial to view this content.
The authors have no conflicts of interest to disclose.
This work was supported by the philanthropic contributions of the John G. and Marie Stella Kenedy Memorial Foundation (Grant #0727033) and the Melanoma Research Alliance. The authors wish to thank the University of Texas MD Anderson Cancer Center Institutional Tissue Bank (ITB) for coordinating tissue distribution and collection and facilitating translational research, as well as Dr. Ignacio Wistuba, Dr. Victor Prieto, the MD Anderson Cancer Center Department of Pathology and the Melanoma Moon Shot Program. Finally, the authors wish to acknowledge all patients and families affected by melanoma.
....Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| Needles | BD | 305167 | |
| Stainless steel disposable scalpels | Miltex | 4-410 | |
| Tissue culture dish | Corning | 353003 | |
| Biopsy Cassettes | Thermo Fisher | 58931 | |
| RNA-stabilizing solution | Ambion | AM7021 | |
| 1.5 ml Eppendorf tubes | Phenix | MAX-815 | |
| 50 ml tubes | Corning | 430290 | |
| 10% Neutral Buffered Formalin | StatLab Medical Products | 28600-5 | |
| Formalin Containers | Fisher Scientific | 23-032-059 | |
| Optimal cutting temperature solution (OCT) | Sakura Finetek | 4583 | |
| Tissue-Tek Cryomold | Sakura Finetek | 4557 | |
| Dnase I | Roche | 10104159001 | |
| Collagenase I | Roche | 11088793001 | |
| 70μm cell strainers | BD Bioscience | 352350 | |
| 96 well round bottom plates | Corning | 3799 | |
| Live/Dead stain solution | Life Technologies | L34957 |
Access restricted. Please log in or start a trial to view this content.